FDA Official Tells Lawmakers Reimportation Would Be Dangerous


By Julie Rovner WASHINGTON, DC (Reuters Health) Jul 25 –

 A proposal under consideration in the Senate to allow individuals and wholesalers to bring back US-made prescription drugs exported to Canada could threaten the safety of the nation’s drug supply, a top official of the Food and Drug Administration told a House subcommittee Thursday.

“Throwing the door open to drugs purchased by individuals directly from Canadian sellers will encourage unscrupulous individuals to devise schemes using Canada as a transshipment point for dangerous products from all points around the globe,” FDA Senior Associate Commissioner William K. Hubbard told the House Energy and Commerce Health Subcommittee. “Web sites touting the availability of supposedly legal drugs from Canada will spring up in large numbers, duping consumers, who will have no way of knowing that the drugs may be illegal, counterfeit or contaminated.”

0 תגובות

השאירו תגובה

רוצה להצטרף לדיון?
תרגישו חופשי לתרום!

כתיבת תגובה

מידע נוסף לעיונך

כתבות בנושאים דומים

התכנים המוצגים באתר זה מיועדים לאנשי צוות רפואי בלבד

אם כבר נרשמת, יש להקליד את פרטי הזיהוי שלך